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Abstract Albeit aging is an inevitable process, the
rate of aging is susceptible to modifications. Dietary
restriction (DR) is a vigorous nongenetic and non-
pharmacological intervention that is known to delay
aging and increase healthspan in diverse species. This
study aimed to compare the impact of different
restricting feeding regimes such as limited daily
feeding (LDF, 60% AL) and intermittent feeding
(IF) on brain energy homeostasis during aging. The
analysis was focused on the key molecules in glucose
and cholesterol metabolism in the cortex and hip-
pocampus of middle-aged (12-month-old) and aged
(24-month-old) male Wistar rats. We measured the
impact of different DRs on the expression levels of
AMPK, glucose transporters (GLUT1, GLUT3,
GLUT4), and the rate-limiting enzyme in the choles-
terol synthesis pathway (HMGCR). Additionally, we
assessed the changes in the amounts of cholesterol, its
metabolite, and precursors following LDF and IF. IF
decreased the levels of AMPK and pAMPK in the
cortex while the increased levels were detected in the
hippocampus. Glucose metabolism was more affected
in the cortex, while cholesterol metabolism was more
influenced in the hippocampus. Overall, the hip-
pocampus was more resilient to the DRs, with fewer
changes compared to the cortex. We showed that LDF
and IF differently affected the brain energy home-
ostasis during aging and that specific brain regions
exhibited distinct vulnerabilities towards DRs. Con-
sequently, special attention should be paid to the DR
application among elderly as different phases of aging
do not respond equally to altered nutritional regimes.
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Introduction
Aging is a gradual, continuous process of natural
changes that happens at the molecular, cellular and
tissue level (Cummings 2007). During early middle
age, many bodily functions begin to gradually decline
and the brain is no exception to this phenomenon.
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However, the rate of aging is modifiable and one of the
environmental factors proven to be very potent in
modulating aging is nutrition.
Dietary restriction (DR) is a vigorous nongenetic
and nonpharmacological intervention that is known to
delay aging and increase healthspan in diverse species
from yeast to mammals (Katewa and Kapahi 2010).
DR is able to improve learning and memory, enhance
synaptic plasticity and neurogenesis, improve behav-
ioral performances of rodents, and counteract age-
related molecular and cellular alterations that impair
cognition (Duan et al. 2001; Anson et al. 2003;
Mattson 2005; Mladenovic Djordjevic et al. 2010;
Smiljanic et al. 2015).
Two different DR paradigms have proven effective
in ameliorating aging in rodents: limited daily feeding
(LDF), with reduced daily food allotment (typically
30–40% of the ad libitum consumption) and intermit-
tent feeding (IF), referring to alternate periods of food
intake with periods of fasting (Anson et al. 2003).
Regardless of the regime applied food restriction is
altering the energy metabolism. The key molecule that
mediates nutrient signaling pathways sensing the
cellular energy status is AMP-activated protein kinase
(AMPK) (Hardie et al. 2012). It is a highly conserved
eukaryotic protein serine/threonine kinase that con-
trols energy homeostasis by switching on catabolic
ATP-generating pathways, including glucose uptake
(Ha et al. 2015) while switching off anabolic ATP
consuming processes. The role of AMPK in the brain
is rather complex. Additionally, to perceiving their
own energy requisite, neurons integrate neuro-hu-
moral signals to assess organismal energy balance, and
AMPK is involved in both circumstances (Ronnett
et al. 2009).
Under normal physiological conditions, the brain is
absolutely dependent on glucose as a fuel source. The
brain comprises about 2% of body mass, but utilizes
25% of the total body glucose (Rossi et al. 2001). The
aging is associated with an increased risk of deterio-
rating systemic control of glucose levels and of the
brain glucose uptake (Craft 2006). Several preclinical
and clinical studies support a role of lowered brain
glucose uptake in age-associated cognitive impair-
ment (Cunnane et al. 2011). As neurons are unable to
produce or store glucose they depend on glucose
transport across the blood–brain barrier (BBB) which
is accomplished by the family of glucose transporters
(GLUTs) (Scheepers et al. 2004). There are fourteen
GLUT protein isoforms expressed in humans, includ-
ing transporters for substrates other than glucose, such
as fructose, myoinositol, and urate. The well-estab-
lished glucose transporter isoforms, GLUTs 1–4, have
distinct regulatory and/or kinetic properties that reflect
their specific roles in cellular and whole body glucose
homeostasis (Thorens and Mueckler 2010). GLUT1 is
the major GLUT isoform expressed in brain endothe-
lial cells (Koranyi et al. 1991; Simpson et al. 2001;
Yeh et al. 2008) and astrocytes (McCall et al. 1996).
GLUT3 is the primary mediator of glucose uptake into
neurons (Leino et al. 1997), localized in neuropils,
mostly in axons and dendrites (Thorens and Mueckler
2010). GLUT4 is expressed in a subset of neurons,
especially in cholinergic neurons of the rat forebrain,
and is often co-expressed in conjunction with GLUT3
(Apelt et al. 1999).
In addition to glucose, cholesterol is also essential
for proper brain functioning. The brain contains 5–10
times more cholesterol than any other organ. The BBB
renders homeostasis of brain cholesterol independent
of circulating cholesterol and consequently choles-
terol in the brain is produced by de novo synthesis
(Dietschy and Turley 2001). In the complex process of
cholesterol biosynthesis the first steroid intermediate
lanosterol can be converted to cholesterol through two
alternative pathways: the Bloch pathway via desmos-
terol, a direct cholesterol precursor, and the Kan-
dutsch-Russell pathway via lathosterol. The
disturbance in cholesterol homeostasis underlies many
neurodegenerative diseases, and with aging represents
a major risk factor for the development of such
pathologies (Valenza et al. 2007; Popp et al. 2013;
Vanmierlo et al. 2015). Data regarding brain choles-
terol metabolism in the course of aging are somewhat
inconsistent (reviewed in Martin et al. 2010). Addi-
tionally, the cholesterol metabolism in different
regions of the brain is not uniform (Smiljanic et al.
2013). The levels of cholesterol precursors were
significantly decreased in the hippocampus in the
course of aging.
While a lot is known about the impact of various
DRs on the metabolic pathways in the body, the
information regarding their effects in the central
nervous system is sparse. Therefore, the aim of our
study was to investigate and compare the impact of
different chronic restricting feeding regimens on brain
energy homeostasis in different aging groups: middle-
aged and aged rats (12- and 24-month-old,
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respectively). To this end, we analyzed expression
patterns of glucose transporters, GLUT1, GLUT3 and
GLUT4, and AMPK and pAMPK in the cortex and
hippocampus of both age groups. We also expanded
our previously published data showing that IF affected
the cholesterol metabolism in the aging brain (Smil-
janic et al. 2014), with the analyses of the effects of
LDF on the concentration of cholesterol and its
metabolites in the brain during aging.
Materials and methods
Animals and treatments
Male Wistar rats were used in this study. All animal
procedures complied with the EEC Directive (86/609/
EEC) on the protection of animals used for experi-
mental and other scientific purposes and were
approved by the Ethical Committee for the Use of
Laboratory Animals of the Institute for Biological
Research ‘‘Sinisa Stankovic’’, University of Belgrade.
The animals were housed under standard conditions
(23 ± 2 C, relative humidity 60–70%, 12-h light/-
dark cycle), and their health status was routinely
checked. Food (standard laboratory chow pellets
containing 8.34% water, 21.61% crude protein,
2.36% crude fat, 6.68% crude fiber, 6.55% crude
ash, 1.95% minerals) was available ad libitum (AL)
until the young adult period (3 months). At that time,
the average daily food consumption was determined
and rats were divided into three groups: the first group
continued to receive food ad libitum (AL group), the
second group was allowed 60% of determined mean
daily intake every day (60% AL-LDF group), and the
third group was fed AL every other day (IF group). All
experimental groups (n = 5 per group) were main-
tained on these dietary regimens until 12 (middle-
aged) and 24 (aged) months of age when they were
sacrificed by decapitation. Brains were quickly
removed, and the cortex and hippocampus were
dissected on ice, collected for subsequent sterol and
protein analysis, and stored at - 80 C until further
use. Blood was collected from the trunk, and the serum
was isolated and frozen.
Serum glucose concentration
Serum glucose was determined using a Randox Lab
GOD/PAP (4-aminophenazone, glucose oxidase, and
peroxidase) Liquid kit, with rat glucose as a standard
(INEP, Belgrade, Serbia). Glucose was determined
after enzymatic oxidation in the presence of glucose
oxidase. The formed hydrogen peroxide reacts after
catalysis of peroxidase, with phenol and 4-aminophe-
nazone to form a red-violet quinoneimine dye that
serves as an indicator. The absorbance was measured
at 500 nm.
Western blot analysis
For Western blot analysis, the tissues were homoge-
nized and sonicated in 10 volumes of RIPA buffer
(50 mMTris–HCl pH 7.5, 150 mM NaCl, 1% NP-40,
0.5% Triton X-100, 0.1% SDS, 1 mM EDTA, 1 mM
EGTA) containing a complete protease inhibitor
cocktail (Roche, Mannheim, Germany) and phos-
phatase inhibitors (25 mM NaF, 5 mM Na4P2O7,
2 mM Na3VO4). Protein concentrations were deter-
mined using the Micro BCA Protein Assay Kit (Pierce
Biotechnology) and bovine serum albumin (BSA) as
standard. Fifteen micrograms of proteins per lane were
separated by SDS PAGE and blotted onto PVDF
membranes. The membranes were blocked with 5%
non-fat dry milk/Tris buffered saline with
0.05%Tween 20 (TBST) (150 mM NaCl, 50 mMTris,
pH 7.4, and 0.05% Tween 20) for 1 h at room
temperature (RT) and incubated with the following
primary antibodies: rabbit anti-Glucose Transporter
GLUT1 antibody (Abcam, ab 652, 1:2000), rabbit
anti-Glucose Transporter GLUT3 antibody (Abcam,
ab 41525, 1:3000), rabbit anti-Glucose Transporter
GLUT4 antibody (Abcam, ab 654, 1:2000), rabbit
anti-AMPKa (Cell Signaling #5831, 1:1000), rabbit
anti-phospho-AMPKa (Cell Signaling #4188, 1:2000)
and rabbit anti-HMGCR antibody (Millipore,
ABS229, 1:1000) overnight at? 4 C. The antibodies
were diluted in TBST. Following several rinses in
TBST, the membranes were incubated for 1 h at RT
with the appropriate horse radish peroxidase (HRP)-
conjugated secondary antibodies (bovine anti-rabbit,
1:5000 from Santa Cruz, sc-2370) diluted in TBST.
HRP-immunoreactive bands were visualized by
enhanced chemiluminescence (ECL, GE Healthcare)
and film (Kodak Biomax) exposure. Ponceau staining
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was used as loading control. Signals were quantified
densitometrically using Image Quant software (v. 5.2,
GE Healthcare) and expressed as relative values (i.e.,
normalized to the corresponding Ponceau staining).
All bends at indicated molecular weight were quan-
tified. Changes in the levels of analyzed proteins in
both LDF and IF experimental group were expressed
as a fold change relative to the appropriate age-
matched control AL group.
Sterol profile determination
The sterol profiles were determined in the cortex and
hippocampus samples as previously described (Lu¨tjo-
hann et al. 2002; Jansen et al. 2013; Smiljanic et al.
2013). Briefly, the tissue samples were spun in a speed
vacuum dryer (12 mbar; Savant AES 1000) for 24 h.
The sterols were extracted from the dried tissue by
adding a 1.5-ml mixture of chloroform/methanol (2:1)
for 24 h at 4 C. Fifty micrograms of 5a-cholestane
(Serva) (50 ll from a stock solution of 5a-cholestane
in cyclohexane; 1 mg/ml) and 1 lg epicoprostanol
(Sigma) (10 ll from a stock solution epicoprostanol in
cyclohexane; 100 lg/ml) were added to 1.125 ml
chloroform/methanol brain extract. One milliliter of
NaOH (1 M) in 80% ethanol was added for alkaline
hydrolysis over 60 min at 61 C. Sterols were subse-
quently extracted with 3 ml of cyclohexane twice. The
organic solvents were evaporated, and the residual
sterols were dissolved in 160 ll n-decane. Subse-
quently, 80 ll of the n-decane samples were trans-
ferred into micro-vials for GC/MS quantification. The
sterols were derivatized to trimethylsilyl (TMSi)
ethers by adding 10 llTMSi reagent (pyridine/hex-
amethylsisilazane/rimethylchlorosilane; 9:3:1, by vol-
ume; all reagents were applied from Merck) and
incubated for 1 h at 64 C. The residual 80 ll of
n-decane samples were diluted with 300 ll n-decane
and derivatized with 30 ll TMSi reagent preceding
analysis of cholesterol by gas chromatography—flame
ionization detection (GC/FID), and its precursors and
metabolites by GC–MS using epicoprocstanol or
deuterium labeled oxysterols, respectively as internal
standards. The individual sterol concentrations (c-
holesterol (lg/mg), 24S-hydroxycholesterol (ng/mg),
lanosterol (ng/mg), lathosterol (ng/mg), desmosterol
(ng/mg)) were related to dry weight of the brain tissue.
Statistical analysis
All values were expressed as the mean ± SEM.
Differences between the experimental groups were
tested using nonparametric Mann–Whitney’s U test
(STATISTICA v. 6.0, StatSoft, Tulsa, OK). Statistical
significance was set at P\ 0.05.
Results
LDF and IF decrease body weight and have
the opposite effect on serum glucose levels
during aging
As the first step to understanding the effects of
different dietary regimes (DRs) on the energy
metabolism in middle-aged and aged rats, we assessed
the effects of IF and LDF on body weight and serum
glucose levels (Fig. 1). Body weight was significantly
decreased following applied dietary restriction regi-
men in comparison to AL-fed controls. In middle-aged
rats reduction of body weight was 32 and 40%
following LDF and IF, respectively. In old animals,
LDF decreased animal’s weight by 25%, and IF by
32%. However, all the animals were normoglycemic.
Nevertheless, glucose levels in 12-month-old animals
were significantly decreased following LDF (25%)
when compared to the control AL animals, while IF
did not alter glucose levels in this age group. Contrary,
in 24-month-old IF significantly lowered glucose
levels (32%) and LDF did not have any effect when
compared with AL animals of the same age.
AMPK and pAMPK levels are differently
regulated following LDF and IF in the cortex
and hippocampus
As the AMPK is the main energy sensor, we next
examined the impact of different DRs on its expres-
sion and phosphorylation, using Western blot analysis
(Fig. 2). Only IF elicited the significant decrease in the
expression of AMPK in the cortex of both middle -
aged and aged rats (51 and 46%, respectively) while
LDF had no effect. Similarly, IF, but not LDF,
decreased the levels of pAMPK (46 and 57%,
respectively) (Fig. 2a). Hippocampal AMPK and
pAMPK expression was not affected with either DR
regimen in the middle-aged rats. In the aged rats,
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however, LDF caused an increase in AMPK and
pAMPK levels (69 and 58%, respectively), while IF
did not have any effect (Fig. 2b). However, in all
experimental groups pAMPK/AMPK ratio remained
unchanged following either LDF and IF in both the
cortex and hippocampus (Fig. 2a, b).
LDF and IF predominantly affect glucose
transporters expression in the cortex of aging
animals
As the brain exclusively uses glucose as the energy
source, its proper functioning depends on the expres-
sion of GLUT family members. Using Western blot
technique we performed a comparative analysis of the
expression of GLUT1, GLUT3 and GLUT 4 under
LDF and IF in the cortex and hippocampus in middle-
aged and aged rats (Fig. 3). GLUT1 expression in the
cortex of 12-month-old animals was not altered by
either LDF or IF, but in the aged animals (24 months),
the expression of GLUT1 was significantly elevated
(30%) under LDF and not altered following IF.
GLUT3 expression was decreased under both LDF
and IF in the cortex of the middle-aged animals (42
and 46%, respectively). However, in the aged animals,
LDF increased (31%) and IF decreased (35%) the
expression of GLUT3. GLUT4 expression in the
cortex of middle-aged rats was affected under LDF
only, which decreased its expression (24%). In the
cortex of aged rats only IF caused the decrease of
Fig. 1 Body weight and serum glucose concentration.
a Changes in the body weight in male Wistar rats succeeding
LDF (light bars) and IF (dark bars). b Glucose concentration in
the rat serum following LDF (light bars) and IF (dark bars). The
line represents the values of control, AL rats. Data are expressed
as the mean ± standard error of the mean. *P\ 0.05 versus
age-matched control
Fig. 2 The effect of long-term DR on the AMPK expression
and its phosphorylation. Western blot analysis of the expression
of AMPK and its phosphorylated form, as well as pAMPK/
AMPK ratio in the rat cortex (a) and hippocampus (b) following
LDF (light bars) and IF (dark bars).Each graph is accompanied
by representative immunoblots. Ponceau S staining of the
membranes served as a control protein loading. Data are
expressed as the mean ± standard error of the mean. *P\ 0.05
versus age-matched control
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GLUT4 (43%) (Fig. 3a). In the hippocampus, GLUT1
and GLUT4 expression was not altered either with
LDF or with IF in both middle-aged and aged animals.
The expression of GLUT3 in the middle-aged rats was
not altered regardless of DR regimens, while in the
aged rats only IF had an effect on the GLUT3
expression eliciting its decrease (44%) (Fig. 3b).
LDF and IF differently affect cholesterol
biosynthesis and the levels of cholesterol
precursors depending on the brain region and age
of the animals
In order to understand how these two dietary
approaches affected the cholesterol metabolism, we
performed Western blot analysis of the expression of
the rate-limiting enzyme in cholesterol synthesis,
HMGCR (Fig. 4a, b) and assessed the levels of
cholesterol, its precursors and specific metabolites
(Fig. 4c, d) using GC/MS. The expression level of
HMGCR in the cortex remained unaltered in both
middle-aged and aged animals regardless of DR
protocol applied. In the hippocampus, however, LDF
caused a decrease in the HMGCR expression (32%) in
the middle-aged rats and an increase in the aged rats
(41%). Contrary to LDF, IF decreased the HMGCR
expression in the hippocampus of aged animals (28%).
Neither DR regimen altered the levels of choles-
terol and its catabolite, 24S-hydroxycholesterol in
either cortex or hippocampus regardless of age groups.
However, both DR regimens had a profound effect on
the concentrations of cholesterol precursors—lanos-
terol and lathosterol depending on the brain regions
and age of the animals. In the middle aged rats IF had
an effect only on lanosterol concentration in the cortex
eliciting its decrease (33%) as compared to control
group. In that same age group, LDF had an effect only
on the concentration of lathosterol in the cortex,
inducing its decrease (20%). Interestingly, in the
cortex of the aged rats, LDF decreased the levels of
lanosterol (19%). IF, however, did not affect the
concentration of any of the cholesterol precursors in
the cortex of aged rats (Fig. 4b). In the hippocampus
of middle- aged rats IF decreased both lano- and
lathosterol concentrations (32 and 35%, respectively)
while LDF downregulated lathosterol only (20%). In
the aged rats LDF triggered the decrease in both the
lano- and lathosterol concentrations in the hippocam-
pus (20 and 20%, respectively). Interestingly, the only
change following IF was an increase (37%) in
desmosterol concentration in the hippocampus of
aged rats (as we previously reported in Smiljanic
et al. 2014) while other metabolites remained unal-
tered (Fig. 4c).
Discussion
Two different experimental DR paradigms that are
widely used are LDF and IF (Anson et al. 2003). A
number of studies and reviews suggest that in general,
LDF and IF produce similar changes regarding
Fig. 3 Expression pattern of GLUT isoforms succeeding long-
term DR. Western blot analysis of the expression of GLUT
isoforms in rat cortex (a) and hippocampus (b) following LDF
(light bars) and IF (dark bars). Each graph is accompanied by
representative immunoblots. Ponceau S staining of the mem-
branes served as a control protein loading. Data are expressed as
the mean ± standard error of the mean. *P\ 0.05 versus age-
matched control
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physiological parameters such as body temperature,
heart rate, blood pressure, and decreased glucose and
insulin levels (Mattson et al. 2003; Yuen and Sander
2014). However, all signals generated by peripheral
systems (such as the gut, fat tissue, liver, and pancreas)
in response to food ingestion/restriction are transmit-
ted to the brain to stimulate or suppress the ‘‘satiety
center’’. These peripheral signals that regulate appetite
and satiety can be episodic (short-term, meal to meal)
and tonic (long-term, days and weeks). Thus, it is not
only that percent of food reduction has a great impact
on energy balance, but also the type of reduction, i.e.,
do animals get food constantly in a reduced manner or
they are exposed to food intermittently. Studies in
young mice showed that LDF and IF feeding regimes
have the similar effect on glucose and insulin levels
but affect differently the serum IGF-1 levels (Anson
et al. 2003). However, aging significantly alters
metabolic processes and the question remains which
DR regime could be more beneficial in older age.
Therefore, we analyzed how these different feeding
paradigms affect the expression of key molecules
involved in the regulation of energy homeostasis in the
brain during aging.
Glucose is the main energy source in the brain. The
glucose level in the CSF is proportional to the one in
the blood, corresponding to 60–70% of the blood
concentration (Mundt and Shanahan 2010). Although
neither LDF nor IF caused hypoglycemia, confirming
the absence of malnutrition in our experimental
setting, they still significantly altered glucose levels
in aging rats. Blood glucose levels in the middle-aged
Fig. 4 The effect of long-term DR on the cholesterol
metabolism in the cortex and hippocampus. Western blot
analysis of the HMGCR expression in the rat cortex (a) and
hippocampus (b) following LDF (light bars) and IF (dark bars).
Each graph is accompanied by representative immunoblots.
Ponceau S staining of the membranes served as a control protein
loading. Gas chromatography/mass spectrometry analysis of the
levels of cholesterol metabolites in the rat cortex (c) and
hippocampus (d) following LDF (light bars) and IF (dark bars).
The line represents the values of control, AL rats. Data are
expressed as the mean ± standard error of the mean. *P\ 0.05
versus age-matched control
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rats appeared more sensitive to LDF while the old rats
were more sensitive to IF. Thus, it is important that
subtle changes within the physiological range of
different parameters should be taken into considera-
tion when applying different dietary regimes to
different age groups.
As neurons are characterized by high metabolic
activity and poor nutrient storage capacity (Vilchez
et al. 2007), it is easy to understand why neurons are
particularly responsive to fluctuations in energy levels.
AMPK is the principal energy sensor in eukaryotic
cells and functions to maintain cellular energy home-
ostasis (Hardie et al. 2012) and thus has a critical role
in neuronal maintenance and survival. AMPK stimu-
lates energy production from glucose and fatty acids
during stress and inhibits energy consumption for
protein, cholesterol, and glycogen synthesis (Stein-
berg and Kemp 2009; Hardie et al. 2012). Dagon et al.
(2005) showed that a moderate LDF (60% AL)
increased hippocampal AMPK activity, induced neu-
rogenesis, and improved cognition, but that severe
LDF (40% AL) over activated AMPK, reduced
cognition, and induced neural apoptosis. AMPK is
thus a regulatory factor balancing between neuronal
growth and death in response to nutritional status and
stress.
AMPK is activated by ATP depletion (increased
AMP/ATP ratio) caused by various stimuli such as
exercise, starvation, hypoxia, cellular pH and redox
status, and increased creatine/phosphocreatine ratio.
However, AMPK is also activated by certain drugs,
hormones, and cellular stressors that do not alter AMP/
ATP ratio (reviewed in Kahn et al. 2005). IF decreased
the expression of AMPK and its phosphorylation in the
cortex of both age groups, while LDF had no impact.
As an overall cellular energy crisis can decrease
AMPK activity, as occurs in the injured brain for
example (Hill et al. 2016), it appears that IF regime is a
stressful condition for the cortex of aging animals.
However, AMPK downregulation can also be caused
by the excess of food/fuel as it was shown that the
surplus of glucose induced the decrease in AMPK
activity in skeletal muscle and the insulin resistance
that accompanies it (Coughlan et al. 2015). It is
possible that AMPK regulatory network reads the IF
regime as an intermittent abundance of food rather
than intermittent fasting, thus reacting with the
decreased AMPK expression. Interestingly, the hip-
pocampus was resistant to the stress-inducing effect of
IF and responded only to LDF and only in aged
animals with increased AMPK and pAMPK levels
probably as a result of stimulation other than blood
glucose levels. AMPK activation can protect hip-
pocampal neurons against glucose deprivation and
glutamate excitotoxicity (Culmsee et al. 2001), and
astrocytes from ceramide-induced apoptosis (Bla´z-
quez et al. 2001). Moreover, recent findings showed
that the activation of AMPK in neurons has the ability
to improve tissue homeostasis in the aging intestine
through the non-cell autonomous induction of autop-
hagy in the intestinal epithelium (Ulgherait et al.
2014). Additionally, it was shown that up-regulation
of AMPK was able to positively affect mitochondrial
development and metabolism (Zhang et al. 2018).
Aging is accompanied with increased oxidative stress
and production of reactive oxygen species (ROS),
mainly from dysfunctional mitochondria (Balaban
et al. 2005). Different brain regions are not equally
vulnerable to oxidative damage by ROS (Hadem et al.
2017). DR is anticipated to lessen the age-related
increase in oxidative stress. Our results suggested that
LDF could represent a significant protection from
oxidative stress in the aged hippocampus since the
levels of both AMPK and pAMPK were increased
following such treatment. However, this result should
be interpreted with caution, since the pAMPK/AMPK
ratio remained unaltered as compared to control.
Hypoglycemia and activated AMPKwere shown to
regulate the expression of glucose transporters in the
brain (Cheng et al. 2003). We analyzed the expression
of GLUT1, GLUT3 and GLUT4 isoforms following IF
and LDF in the cortex and hippocampus of aging
animals. As the blood glucose levels were significantly
lower in 12-month-old animals under LDF we
expected the increase in GLUT isoforms expression.
However, in the cortex of middle-aged animals the
expression of GLUT3, and to a lesser extent GLUT4,
was decreased. In contrast, in spite of the unaltered
glucose in 24-month-old LDF animals, GLUT3 and
GLUT1 cortical expression was significantly
increased suggesting that cortical requirement for
glucose intake is stimulated with the chronic restric-
tion of the food consumption at that age. However, the
expression of GLUTs was downregulated under IF in
aging rats in spite of the decreased glucose blood
levels. This is probably the result of the decreased
expression and phosphorylation of AMPK. On the
other hand, GLUT3 translocation could represent a
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potential mechanism for sustaining glucose uptake
into neurons, even in the conditions when GLUT3
levels were reduced (Ximenes da Silva et al. 2002). As
AMPK downregulation was shown to inhibit the
translocation of GLUT3 to the membrane (Weisova´
et al. 2009), the reduced oxidative phosphorylation as
a consequence of reduced food intake could function
as another signal to neuronal cells to mobilize GLUT3
at the neuronal membrane surface. It has been shown
that AMPK activation in BBB-derived endothelial
cells directs the trafficking of GLUT1 intracellular
pools to the plasma membrane, thereby increasing the
endothelial sugar transport capacity. It is possible that
the observed down regulation of AMPK in the cortex
of aged rats can induce the opposite effect on the
localization of GLUT1. Interestingly, the expression
of GLUT isoforms in the hippocampus was mostly
unaffected except the slight decrease of GLUT3 in
24-month-old rats subjected to the IF.
Although the overall cholesterol content remains
stable following different dietary manipulations (Pal-
lottini et al. 2003; Mulas et al. 2005; Hayakawa et al.
2007; Fon Tacer et al. 2010; Smiljanic et al. 2014), a
significant decrease in the levels of cholesterol
precursors was detected even after short-term fasting
(20 h) (Fon Tacer et al. 2010). Similarly, we have
shown that cholesterol content remained unchanged in
the brain following both LDF and IF. Stable choles-
terol levels could be attributed to the fact that the
major pool of cholesterol in the brain resides in the
myelin membranes and has quite slow turnover
(Anson et al. 2003). However, lack of the changes in
overall cholesterol content can blur changes in the
smaller, but more active pool of cholesterol in the
membrane microdomains such as lipid rafts. The
influence of both DR protocols on cholesterol
metabolism is observed on the level of cholesterol
precursors. These alterations are important since
intermediates in cholesterol biosynthesis pathway are
also biologically active molecules with a plethora of
regulatory functions. Among other roles, they are able
to activate nuclear receptor X, which further affects
the regulation of genes involved in lipid metabolism
and inflammation (Fon Tacer et al. 2010). This study
showed that LDF and IF elicited significant and
specific changes in the levels of cholesterol precursors.
These changes vary depending on the age of the rats
and brain region analyzed.
Both DR protocols decreased the levels of choles-
terol precursors, lano- and lathosterol, suggesting the
consequent reduction of cholesterol synthesis. Lanos-
terol is the first steroid intermediate in cholesterol
synthesis. Interestingly we observed the increase in the
levels of desmosterol in the hippocampus of the aged
animals under IF. In all other experimental groups,
desmosterol was unaltered. This change could point to
the ability of IF to promote an age-related adaptive
mechanism. The fact that desmosterol is a direct
cholesterol precursor produced in the Bloch choles-
terol synthesis pathway prevailing in young individ-
uals (Lu¨tjohann et al. 2002) suggests a switch to a less
energy-consuming synthesis pathway in the old ani-
mals exposed to IF (Smiljanic et al. 2014). Thus, IF,
but not LDF had the potency to promote energy-saving
mechanism in the hippocampus. Our previous study
(Smiljanic et al. 2013) showed that desmosterol is the
most abundant cholesterol precursor in the brain
during the entire aging process. Additionally, its level
in the hippocampus is notably higher than in the
cortex. This difference could be attributed, at least
partially, to the process of neurogenesis that takes
place in the adult dentate gyrus (Couillard-Despres
et al. 2011) and to the role of cholesterol in the
myelination process (Smith 1968). Obtained data
illustrated that the cortex and hippocampus responded
differently to DRs applied regarding the changes in
glucose and cholesterol metabolism. The summary of
all the changes observed under these two different
DRs is outlined in Fig. 5. Glucose metabolism
estimated through the expression levels of glucose
transporters is more susceptible to DRs in the cortex,
while more pronounced changes in cholesterol
metabolism following DRs were observed in the
hippocampus. Because glucose is obtained exclu-
sively from the blood, the density of brain capillaries
that varies significantly within the brain depending on
the location and energy needs can have the role in
these different sensitivities to specific DRs (Klein
et al. 1986). Additionally, various pathological, phys-
iological, and environmental factors are able to
influence changes in capillary density. Cholesterol,
on the other hand, is produced in situ, but the demands
for cholesterol are region specific (Dietschy and
Turley 2001; Vanmierlo et al. 2010). The hippocam-
pus, as the site of adult neurogenesis, appears more
sensitive to the changes in cholesterol metabolism and
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adaptively responds to DR effects with altered
cholesterol synthesis pathway.
This study showed that the effects of LDF and IF
vary greatly depending on the age and brain region
analyzed. Therefore, the age should be considered as
an important factor when choosing the specific DR
regime among elderly as different phases of aging
have different energy demands. Further studies are
necessary in order to achieve optimal effects of DR as
a nongenetic and nonpharmacological intervention in
order to delay aging and to increase active and healthy
lifespan.
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